FlowTriever System for Pulmonary Embolism: A Review of Clinical Evidence.
| Autor: | Haner Wasserstein D; From the New York Medical College at Westchester Medical Center, Valhalla, NY., Frishman WH; Department of Internal Medicine, New York Medical College at Westchester Medical Center, Valhalla, NY. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cardiology in review [Cardiol Rev] 2023 Nov 01. Date of Electronic Publication: 2023 Nov 01. |
| DOI: | 10.1097/CRD.0000000000000605 |
| Abstrakt: | Pulmonary embolism (PE) is a significant cause of cardiovascular mortality, and its incidence has been increasing due to the growing aging population. Systemic or catheter-directed thrombolytic treatment for PE has an increased risk of bleeding that may offset the benefit in some patients. Mechanical thrombectomy devices such as the FlowTriever System are designed to resolve vascular occlusion and correct ventilation-perfusion mismatch without the need for thrombolytic drugs. This review covers the FlowTriever system, clinical data from the FlowTriever Pulmonary Embolectomy Clinical Study, FlowTriever for Acute Massive Pulmonary Embolism, and FlowTriever All-comer Registry for Patient Safety and Hemodynamics trials, and real-world experiences, demonstrating its safety and effectiveness in treating intermediate-risk and high-risk PE. Additionally, we explore off-label uses of the FlowTriever System for various large vessel thromboses. Competing Interests: Disclosure: The authors have no conflicts of interest to report. (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|